Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 38 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (24)
P 1 (2)
P 2 (3)
P 3 (2)

Trial Status

Recruiting14
Not Yet Recruiting10
Completed9
Active Not Recruiting2
Enrolling By Invitation2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT07764211Not Yet RecruitingPrimary

Multimodal Cohort Study of Generalized Anxiety Disorder

NCT06969170Phase 2RecruitingPrimary

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

NCT07024758Not ApplicableActive Not Recruiting

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

NCT07541443Not ApplicableNot Yet RecruitingPrimary

Miles for Mental Health

NCT07712159Not ApplicableNot Yet Recruiting

Temporal Interference Transcranial Alternating Current Stimulation for Major Depressive Disorder and Generalized Anxiety Disorder

NCT07429578Not ApplicableRecruitingPrimary

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

NCT06846320Phase 2RecruitingPrimary

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

NCT07648797Not ApplicableNot Yet RecruitingPrimary

Transcranial Alternating Current Stimulation to Enhance Mindfulness Therapy in Generalized Anxiety Disorder

NCT07640945Not ApplicableNot Yet RecruitingPrimary

MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder

NCT07430800Not ApplicableRecruitingPrimary

Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety

NCT07620340Not ApplicableNot Yet RecruitingPrimary

AI-Supported Therapy for Depression and Anxiety Compared With Standard CBT

NCT07604753Recruiting

Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental Disorders

NCT07329673Recruiting

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

NCT06198023Not ApplicableRecruiting

Targeting Social Function in Anxiety and Eating Disorders

NCT07391020Not ApplicableRecruitingPrimary

Text Message Safety Behavior Fading for Pathological Worry

NCT06937892Not ApplicableRecruitingPrimary

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

NCT06804525Recruiting

LHC-CIDI-5 in Hong Kong

NCT07123467Phase 3RecruitingPrimary

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

NCT07228143Not ApplicableRecruitingPrimary

Stepped Care Treatment for Anxiety Resilience

NCT07129408Completed

Epidemiological Study on the Prevalence of Mental Disorders in Slovakia

Scroll to load more

Research Network

Activity Timeline